cover image - Lung Cancer, 1st Edition
ISBN: 9780323695732
Copyright: 2024
Publication Date: 10-18-2023
Page Count: 352
Imprint: Elsevier
List Price: $230.99

Lung Cancer, 1st Edition

by Erin Alexis Gillaspie, MD, MPH, FACS, Leora Horn, MD, MSc, MHPE and Amanda S. Cass, PharmD

Hardcover

cover image - Lung Cancer, 1st Edition
ISBN: 9780323695732
Copyright: 2024
Publication Date: 10-18-2023
Page Count: 352
Imprint: Elsevier
List Price: $230.99
In Stock
Important note
Please note
This item has low stock levels and may be back-ordered. We'll let you know if it is back-ordered, and you will not be charged until the item ships.
    • Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more. 

    • Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies. 

    • Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and  PET/CT and CT imaging for diagnosis and treatment planning. 

    • Features “Top 5 Clinical Pearls” at the beginning of each chapter. 

    • Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective. 

    • An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. 

  • 1 Lung Cancer Screening and Prevention
    2 Lung Cancer: Diagnostic Techniques
    3 Histology and Molecular Testing
    4 Surgical Considerations in Lung Cancer Treatment
    5 Surgically Resectable Disease
    6 Oligometastatic Disease
    7 Locally Advanced Non–Small Cell Lung Cancer
    8 First-Line Therapy
    9 Second-Line Therapy in Advanced Non–Small Cell Lung Cancer
    10 Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Clinical Approach
    11 Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
    12 Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
    13 Immunotherapy
    14 Small Cell Lung Cancer
    Index
  • Erin Alexis Gillaspie, MD, MPH, FACS, Leora Horn, MD, MSc, MHPE and Amanda S. Cass, PharmD
In Stock
Important note
Please note
This item has low stock levels and may be back-ordered. We'll let you know if it is back-ordered, and you will not be charged until the item ships.